ScopeAmbulanzzentrum UKSH Genetisches MVZ Lübeck/Kiel Humangenetik
Official name: Ambulanzzentrum des UKSH gemeinnützige GmbH Genetisches MVZ Lübeck / Kiel Fachbereich Humangenetik, Standorte: Ratzeburger Allee 160, 23538 Lübeck; Arnold-Heller-Straße 3, 24105 Kiel
76 capabilities
Accredited since June 2025
Verified Apr 2026
One of 3,039 in Germany
Details
Ratzeburger Allee 160
Lübeck 23538 , Germany
Lübeck 23538 , Germany
Accreditation
Active
DAkkS
D-ML-13314-03-00
Focuses on human genetics testing in cytogenetics and molecular human genetics, using PCR and next-generation sequencing methods on blood and DNA samples to identify genetic syndromes and inherited conditions.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13314-03-00
Status
ActiveSince
11 June 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFSend an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.
Test Capabilities (76)
| Standard Reference | Description | Category |
|---|---|---|
| Angeborener Chromosomensatz | angeborener Chromosomensatz | Biocompatibility (ISO 10993) |
| Erworbener Chromosomensatz | erworbener Chromosomensatz | Biocompatibility (ISO 10993) |
| Akute myeloische Leukämie | Akute myeloische Leukämie | Chromatography (GC, HPLC) |
| (AR) | SBMA (AR) | Food Safety Testing |
| AITL (TET2, DNMT3A, RHOA | AITL (TET2, DNMT3A, RHOA | Food Safety Testing |
| Aderhautmelanom (GNAQ Exon | Aderhautmelanom (GNAQ Exon | Food Safety Testing |
| Akute myeloische Leukämie/ | Akute myeloische Leukämie/ | Food Safety Testing |
| Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5) | Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5) | Food Safety Testing |
| CLL (TP53, NOTCH1 Exon 34, SF3B1 | CLL (TP53, NOTCH1 Exon 34, SF3B1 | Food Safety Testing |
| CMML (TET2, ASXL1 Exon 13, SRSF2 | CMML (TET2, ASXL1 Exon 13, SRSF2 | Food Safety Testing |
| DRPLA (ATN1) | DRPLA (ATN1) | Food Safety Testing |
| Desaminase-Mangel (AMPD1 | Desaminase-Mangel (AMPD1 | Food Safety Testing |
| Exon 13-16, BIRC3, MYD88 | Exon 13-16, BIRC3, MYD88 | Food Safety Testing |
| FMR1) | Fra(X)-Syndrom, FXTAS (FMR1) | Food Safety Testing |
| Friedreich Ataxie (FXN) | Friedreich Ataxie (FXN) | Food Safety Testing |
| Huntington-like (TBP, JPH3) | Huntington-like (TBP, JPH3) | Food Safety Testing |
| Myelodysplastisches Syndrom (FLT3- | Myelodysplastisches Syndrom (FLT3- | Food Safety Testing |
| Myelodysplastisches Syndrom/ | Myelodysplastisches Syndrom/ | Food Safety Testing |
| (APC, MUTYH) | (APC, MUTYH) | Molecular Diagnostics / PCR |
| (CYP21A2) | 21-Hydroxylasemangel (CYP21A2) | Molecular Diagnostics / PCR |
| (GJB2 ) | Schwerhörigkeit (GJB2) | Molecular Diagnostics / PCR |
| (SF3B1, TP53, NPM1, FLT3 (TKD, ITD), ASXL1, BCOR, CBL, DNMT3A, ETV6, EZH2, IDH1, IDH2, KRAS, NRAS, RUNX1, SETBP1, SRSF2, STAG2, U2AF1 und TET2) | (SF3B1, TP53, NPM1, FLT3 (TKD, ITD), ASXL1, BCOR, CBL, DNMT3A, ETV6, EZH2, IDH1, IDH2, KRAS, NRAS, RUNX1, SETBP1, SRSF2, STAG2, U2AF1 und TET2) | Molecular Diagnostics / PCR |
| (SHOX ) | Kleinwuchs (SHOX) | Molecular Diagnostics / PCR |
| (STK11) | Peutz-Jeghers-Syndrom (STK11) | Molecular Diagnostics / PCR |
| (TP53) | Li-Fraumeni-Syndrom (TP53) | Molecular Diagnostics / PCR |
| (TP53, NRAS, KRAS, BRAF, BIRC3, JAK3, PDGFRA) | (TP53, NRAS, KRAS, BRAF, BIRC3, JAK3, PDGFRA) | Molecular Diagnostics / PCR |
| 4/5, GNA11 Exon 4/5, SF3B1 | 4/5, GNA11 Exon 4/5, SF3B1 | Molecular Diagnostics / PCR |
| Aderhautmelanom, erblich (BAP1, MBD4) | Aderhautmelanom, erblich (BAP1, MBD4) | Molecular Diagnostics / PCR |
| Adrenogenitale Syndrom (CYP11A1, STAR, HSD3B2, CYP17A1, CYP11B1, POR) | Adrenogenitale Syndrom (CYP11A1, STAR, HSD3B2, CYP17A1, CYP11B1, POR) | Molecular Diagnostics / PCR |
| Cowden-Syndrom (PTEN) | Cowden-Syndrom (PTEN) | Molecular Diagnostics / PCR |
| Deletion/Duplication Syndrom | Deletion/Duplication Syndrom | Molecular Diagnostics / PCR |
| DiGeorge; 22q11.2 | DiGeorge; 22q11.2 | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom (COL3A1, COL5A1, COL5A2, TNXB) | Ehlers-Danlos-Syndrom (COL3A1, COL5A1, COL5A2, TNXB) | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom (COL3A1, TNXB) | Ehlers-Danlos-Syndrom (COL3A1, TNXB) | Molecular Diagnostics / PCR |
| Entwicklungsstörung | Entwicklungsstörung | Molecular Diagnostics / PCR |
| Exomsequenzierung (SNV, CNV) | Exomsequenzierung (SNV, CNV) | Molecular Diagnostics / PCR |
| GJB6) | Schwerhörigkeit (GJB6) | Molecular Diagnostics / PCR |
| Genomsequenzierung (SNV, CNV, Repeats) | Genomsequenzierung (SNV, CNV, Repeats) | Molecular Diagnostics / PCR |
| HBOC (BRCA1, BRCA2, ATM, BARD1, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53) | HBOC (BRCA1, BRCA2, ATM, BARD1, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53) | Molecular Diagnostics / PCR |
| HBOC (BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D) | HBOC (BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D) | Molecular Diagnostics / PCR |
| HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM) | HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM) | Molecular Diagnostics / PCR |
| Hereditäre Dystonie (THAP1) | Hereditäre Dystonie (THAP1) | Molecular Diagnostics / PCR |
| Hereditäres Magenkarzinom (CDH1) | Hereditäres Magenkarzinom (CDH1) | Molecular Diagnostics / PCR |
| Huntington Krankheit (HTT) | Huntington Krankheit (HTT) | Molecular Diagnostics / PCR |
| Li-Fraumeni-Syndrom (TP53, CHEK2) | Li-Fraumeni-Syndrom (TP53, CHEK2) | Molecular Diagnostics / PCR |
| Loeys-Dietz-Syndrom (SMAD3, TGFB2, TGFBR1, TGFBR2) | Loeys-Dietz-Syndrom (SMAD3, TGFB2, TGFBR1, TGFBR2) | Molecular Diagnostics / PCR |
| Marfan Syndrom (FBN1, TGFBR2) | Marfan-Syndrom (FBN1, TGFBR2) | Molecular Diagnostics / PCR |
| Multiples Myelom/Plasmozytom | Multiples Myelom/Plasmozytom | Molecular Diagnostics / PCR |
| Myelodysplastisches Syndrom | Myelodysplastisches Syndrom | Molecular Diagnostics / PCR |
| Neurofibromatose (NF1) | Neurofibromatose (NF1) | Molecular Diagnostics / PCR |
| Pankreaskarzinom (BRCA1, BRCA2, CDKN2A, STK11, PALB2, ATM, CHEK2, APC, TP53, MLH1, MSH2, MSH6, PMS2, EPCAM, VHL) | Pankreaskarzinom (BRCA1, BRCA2, CDKN2A, STK11, PALB2, ATM, CHEK2, APC, TP53, MLH1, MSH2, MSH6, PMS2, EPCAM, VHL) | Molecular Diagnostics / PCR |
| Parkinson (PARK2, SNCA, PINK1, UCHL1, PARK7, ATP13A2, LRRK2) | Parkinson (PARK2, SNCA, PINK1, UCHL1, PARK7, ATP13A2, LRRK2) | Molecular Diagnostics / PCR |
| Polyposis, adenomatös: FAP / MAP | Polyposis, adenomatös: FAP, MAP | Molecular Diagnostics / PCR |
| Polyposis, juvenil: JPS (BMPR1A, SMAD4) | Polyposis, juvenil: JPS (BMPR1A, SMAD4), SNV | Molecular Diagnostics / PCR |
| Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM) | Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM) | Molecular Diagnostics / PCR |
| RNU4-2 assoziierte | RNU4-2 assoziierte | Molecular Diagnostics / PCR |
| Rett-Syndrom (MECP2) | Rett-Syndrom (MECP2) | Molecular Diagnostics / PCR |
| Spinocerebelläre Ataxien (SCA 1, 3, 6, 7, 8, 10, 12, 17) | Spinocerebelläre Ataxien (SCA 1, 3, 6, 7, 8, 10, 12, 17) | Molecular Diagnostics / PCR |
| p.Val617Phe und Exon 12, CALR | p.Val617Phe und Exon 12, CALR | Molecular Diagnostics / PCR |
| (NPM1, FLT3 (TKD, ITD), CEBPA, TP53, ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, ZRSR2, IDH1 p.Arg132 und IDH2 | (NPM1, FLT3 (TKD, ITD), CEBPA, TP53, ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, ZRSR2, IDH1 p.Arg132 und IDH2 | Other |
| -TKD, NPM1 Exon 11) | -TKD, NPM1 Exon 11) | Other |
| CARD11, MYD88 p.Leu265Pro) | CARD11, MYD88 p.Leu265Pro) | Other |
| Exon 1, RUNX1, NRAS, KRAS, SETBP1) | Exon 1, RUNX1, NRAS, KRAS, SETBP1) | Other |
| Exon 9, MPL Exon 10) | Exon 9, MPL Exon 10) | Other |
| ITD/LM) | ITD/LM) | Other |
| LGL (STAT3 Exon 21, STAT5B Exon | LGL (STAT3 Exon 21, STAT5B Exon | Other |
| MPL, TET2, ASXL1, EZH2, DNMT3A, IDH1, IDH2, SRSF2, SF3B1, U2AF1, ZRSR2, CBL, KRAS, NRAS, STAG2, TP53) | MPL, TET2, ASXL1, EZH2, DNMT3A, IDH1, IDH2, SRSF2, SF3B1, U2AF1, ZRSR2, CBL, KRAS, NRAS, STAG2, TP53) | Other |
| Myeloproliferative Neoplasie (JAK2 | Myeloproliferative Neoplasie (JAK2 | Other |
| c.133C>T) | c.133C>T) | Other |
| p.Arg140 und p.Arg172) | p.Arg140 und p.Arg172) | Other |
| p.Arg625) | p.Arg625) | Other |
| p.Gly17, IDH2 p.Arg172) | p.Gly17, IDH2 p.Arg172) | Other |
| p.Leu265Pro) | p.Leu265Pro) | Other |
| (POLD1, POLE, NTHL1, MSH3) | (POLD1, POLE, NTHL1, MSH3) | Spectroscopy (XRF, ICP, AAS) |
| Noonan-Syndrom (PTPN11, SOS1, RAF1, RIT1, BRAF, KRAS) | Noonan-Syndrom (PTPN11, SOS1, RAF1, RIT1, BRAF, KRAS) | Spectroscopy (XRF, ICP, AAS) |
| Sotos-Syndrom (NSD1) | Sotos-Syndrom (NSD1) | Spectroscopy (XRF, ICP, AAS) |